Solriamfetol: Overpriced, Hard to Get, and Underwhelming — Why FL-Modafinil Wins
TL;DR Solriamfetol (Sunosi) is a dopamine-norepinephrine reuptake inhibitor (DNRI) FDA-approved for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea. Binding affinity is weak: Ki